BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 28, 2014
View Archived Issues
Repurposing dopamine receptor antagonists antipsychotic for the treatment of brain cancer
Read More
TG-1042 shows clinical benefit in phase II study in cutaneous B-cell lymphoma
Read More
Guerbet and Sirtex Medical to collaborate on trials in liver cancer
Read More
Merck & Co. designs improved pan-genotypic HCV NS3/4A protease inhibitors
Read More
Scientists at RespiVert and Topivert Pharma synthesize novel protein kinase inhibitors
Read More
Cancer Research UK begins vaccine trial against cancer caused by Epstein-Barr virus
Read More
Courtagen Life Sciences to provide genetic testing in RP-103 study
Read More
Effective and safe silencing of CTGF with RXI-109 expected to inhibit skin scarring
Read More
Daiichi Sankyo outlines plans for TaNeDS program in 2014
Read More
NICE final guidance recommends MabThera for ANCA-associated vasculitis
Read More
Dimerix Bioscience raises funds to advance DMX-200
Read More
First patient enrolled in phase IIa trial of ORMD-0801 in type 1 diabetes
Read More
Alimera Sciences resubmits Iluvien NDA to FDA
Read More
Enrollment begins in phase III study of ZS-9 in patients with hyperkalemia
Read More
Xenon Pharmaceuticals and Genentech establish new pain genetics collaboration
Read More
First patient dosed in Norgine and Innovacell's phase IIb trial of ICEF-15
Read More
Pfizer achieves primary endpoint in phase IIIb study of Genotropin
Read More
Gemigliptin/metformin fixed-dose combination shows promise in healthy volunteers
Read More
Adipophilin as a potential new marker for Burkitt's lymphoma
Read More
Mast Therapeutics begins phase II study of MST-188 in acute lower limb ischemia
Read More
Genmab achieves second milestone in daratumumab collaboration with Janssen
Read More
Bristol-Myers Squibb patents new JAK inhibitors
Read More
Researchers at Plexxikon design novel agents for cancer
Read More
AbbVie discloses new NO production inhibitors
Read More
Transgene and partners outline development plan for Pexa-Vec
Read More
EMA validates ledipasvir/sofosbuvir MAA and grants accelerated assessment
Read More